ObsEva (OBSV) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends OBSV vs. RNXT, PMN, LIAN, NXTC, DRRX, KALA, DARE, FBRX, LGVN, and LPCNShould you be buying ObsEva stock or one of its competitors? The main competitors of ObsEva include RenovoRx (RNXT), ProMIS Neurosciences (PMN), LianBio (LIAN), NextCure (NXTC), DURECT (DRRX), KALA BIO (KALA), Daré Bioscience (DARE), Forte Biosciences (FBRX), Longeveron (LGVN), and Lipocine (LPCN). These companies are all part of the "pharmaceutical products" industry. ObsEva vs. RenovoRx ProMIS Neurosciences LianBio NextCure DURECT KALA BIO Daré Bioscience Forte Biosciences Longeveron Lipocine RenovoRx (NASDAQ:RNXT) and ObsEva (NASDAQ:OBSV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment. Do analysts recommend RNXT or OBSV? RenovoRx presently has a consensus target price of $6.50, suggesting a potential upside of 420.00%. Given RenovoRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe RenovoRx is more favorable than ObsEva.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RenovoRx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00ObsEva 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to RNXT or OBSV? In the previous week, ObsEva had 1 more articles in the media than RenovoRx. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for RenovoRx. RenovoRx's average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score. Company Overall Sentiment RenovoRx Neutral ObsEva Neutral Which has preferable valuation and earnings, RNXT or OBSV? RenovoRx has higher earnings, but lower revenue than ObsEva. RenovoRx is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRenovoRxN/AN/A-$10.23M-$0.57-2.19ObsEva$20.11M0.00-$58.38M-$0.92N/A Is RNXT or OBSV more profitable? RenovoRx's return on equity of -205.96% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets RenovoRxN/A -205.96% -110.01% ObsEva N/A -416.36%-92.01% Which has more risk and volatility, RNXT or OBSV? RenovoRx has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, ObsEva has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Do insiders & institutionals have more ownership in RNXT or OBSV? 3.1% of RenovoRx shares are held by institutional investors. Comparatively, 17.5% of ObsEva shares are held by institutional investors. 7.1% of RenovoRx shares are held by company insiders. Comparatively, 14.4% of ObsEva shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer RNXT or OBSV? ObsEva received 310 more outperform votes than RenovoRx when rated by MarketBeat users. Likewise, 51.12% of users gave ObsEva an outperform vote while only 47.37% of users gave RenovoRx an outperform vote. CompanyUnderperformOutperformRenovoRxOutperform Votes947.37% Underperform Votes1052.63% ObsEvaOutperform Votes31951.12% Underperform Votes30548.88% SummaryObsEva beats RenovoRx on 8 of the 15 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get ObsEva News Delivered to You Automatically Sign up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBSV vs. The Competition Export to ExcelMetricObsEvaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.94M$6.57B$5.14B$9.08BDividend YieldN/A2.98%5.09%4.23%P/E Ratio-0.1110.5089.8217.18Price / SalesN/A195.801,116.21116.95Price / CashN/A57.1642.8937.86Price / BookN/A5.094.784.78Net Income-$58.38M$151.83M$120.23M$225.60M ObsEva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150Analyst ForecastNews CoverageRNXTRenovoRx1.2324 of 5 stars$1.27-0.8%$6.50+411.8%+76.1%$30.48MN/A-2.256Positive NewsGap UpPMNProMIS Neurosciences1.0717 of 5 stars$0.91-2.7%N/A-20.2%$29.58M$10,000.00-9.306Positive NewsLIANLianBioN/A$0.27flat$3.50+1,194.4%-94.2%$29.22MN/A-0.33110NXTCNextCure4.2168 of 5 stars$1.02-5.6%$4.00+292.2%-14.9%$28.57MN/A-0.5290Positive NewsDRRXDURECT2.6267 of 5 stars$0.92+22.0%$5.00+446.3%+89.2%$28.41M$8.59M-1.3980Analyst ForecastNews CoverageKALAKALA BIO3.8466 of 5 stars$6.10-1.3%$15.00+145.9%-13.3%$28.12M$3.89M-0.5030Gap DownDAREDaré Bioscience1.5891 of 5 stars$3.19+0.3%$24.00+652.4%-31.1%$27.75M$1.88M-5.3930Analyst ForecastGap DownFBRXForte Biosciences1.6824 of 5 stars$19.00-17.9%$23.58+24.1%+65,237.8%$27.74MN/A-1.315LGVNLongeveron3.4375 of 5 stars$1.84-1.1%$8.67+371.2%-89.8%$27.29M$1.89M-0.3023LPCNLipocine1.531 of 5 stars$4.97-1.0%$10.00+101.2%+63.4%$26.58M$7.92M-6.6110News Coverage Related Companies and Tools Related Companies RenovoRx Alternatives ProMIS Neurosciences Alternatives LianBio Alternatives NextCure Alternatives DURECT Alternatives KALA BIO Alternatives Daré Bioscience Alternatives Forte Biosciences Alternatives Longeveron Alternatives Lipocine Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OBSV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ObsEva SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ObsEva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
